Drugs / VM4-037
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT00884520 | Apr 2009 → Mar 2010 | carcinoma of liver and intrahepatic biliary tract, head and neck cancer, lung cancer, renal cell carcinoma +1 | Siemens Molecular Imaging | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VM4-037 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00884520 ↗ |
| Modality | Diagnostic / imaging agent | “[F-18]VM4-037 is being developed as a diagnostic radiopharmaceutical for PET imaging.” NCT00884520 ↗ |
| Route | Intravenous | “The [F-18]VM4-037 will be administered to each qualified subject via a bolus intravenous (IV) injection.” NCT00884520 ↗ |